ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

August 16, 1991

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs

May 30, 1980

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011